Thyroid Cancer clinical trials

Explore recruiting thyroid cancer clinical trials.

Recruiting thyroid cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thyroid Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of metformin effect on the fertility of women treated with 131I for thyroid cancer

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Biomarker Phase II Study Of Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients

Hungary, Poland, Romania, Croatia

Therapeutic use (Phase IV) EU CTIS Study details

[18F]Tetrafluoroborate PET/CT for the Detection of Differentiated Thyroid Cancer: A Phase II Imaging Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy

Romania, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Thyroid Cancer trials by city

Thyroid Cancer in Toronto Thyroid Cancer in Vancouver Thyroid Cancer in Montreal Thyroid Cancer in Calgary Thyroid Cancer in Edmonton Thyroid Cancer in Ottawa Thyroid Cancer in Winnipeg Thyroid Cancer in Quebec City Thyroid Cancer in Hamilton Thyroid Cancer in Kitchener Thyroid Cancer in London Thyroid Cancer in Halifax Thyroid Cancer in New York Thyroid Cancer in Los Angeles Thyroid Cancer in Chicago Thyroid Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease